Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data

详细信息    查看全文

• 作者：Preeti Pathela ; Dr.P.H.^a ; ^{ppathela@health.nyc.gov" class="auth_mail" title="E-mail the corresponding author} ; Kelly Jamison ; M.P.H.^a ; Vikki Papadouka ; Ph.D.^b ; Rezaul Kabir ; M.B.B.S.^b ; Lauri E. Markowitz ; M.D.^c ; Eileen F. Dunne ; M.D.^c ; ^d ; Julia A. Schillinger ; M.D.^a ; ^c
• 关键词：Adolescents ; HPV vaccination ; STD clinics ; Immunization registry
• 刊名：Journal of Adolescent Health
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：59
• 期：6
• 页码：710-715
• 全文大小：398 K

文摘

Human papillomavirus (HPV) vaccine is recommended for adolescents. By the end of 2013, 64% of female and 40% of male New York City residents aged 13–18 years had received ≥1 HPV vaccine dose. Adolescents attending sexually transmitted disease (STD) clinics are at high risk for HPV exposure and could benefit from vaccination. Our objective was to estimate HPV vaccination coverage for this population.

Methods

We matched records of New York City's STD clinic patients aged 13–18 years during 2010–2013 with the Citywide Immunization Registry. We assessed HPV vaccine initiation (≥1 dose) and series completion (≥3 doses among those who initiated) as of clinic visit date and by patient demographics. We compared receipt of ≥1 dose for HPV, tetanus-diphtheria-acellular pertussis, and meningococcal conjugate vaccine.

Results

Eighty-two percent of clinic attendees (13,505/16,364) had records in the Citywide Immunization Registry. Receipt of ≥1 HPV dose increased during 2010–2013 (females: 57.6%–69.7%; males: 1.5%–36.3%). Among females, ≥1-dose coverage was lowest among whites (53.4%) and highest among Hispanics (73.3%); among males, ≥1-dose coverage was lowest among whites (6.9%) and highest among Asians (20.9%). Series completion averaged 57.7% (females) and 28.0% (males), with little variation by race/ethnicity or poverty level. Receipt of ≥1 dose was 59.7% for HPV, 82% for tetanus-diphtheria-acellular pertussis, and 76% for meningococcal conjugate vaccines.

Conclusions

HPV vaccine initiation and completion were low among adolescent STD clinic patients; coverage was lower compared with other recommended vaccines. STD clinics may be good venues for delivering HPV vaccine, thereby enhancing efforts to improve HPV vaccination.